Výsledky vyhledávání - "Verouden, Niels J."

Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients

Autor: van der Sangen, Niels M. R., Claessen, Bimmer E. P. M., Küçük, I. Tarik, den Hartog, Alexander W., Baan, Jan, Beijk, Marcel A.M., Delewi, Ronak, van de Hoef, Tim P., Knaapen, Paul, Lemkes, Jorrit S., Marques, Koen M., Nap, Alexander, Verouden, Niels J. W., Marije Vis, M., de Winter, Robbert J., Kikkert, Wouter J., Appelman, Yolande, Henriques, Jose P. S.

Publikováno v: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 19(1), 63-72. EuroPCR
EuroIntervention, 19(1), 63-72. EuroPCR
van der Sangen, N M R, Claessen, B E P M, Küçük, I T, den Hartog, A W, Baan, J, Beijk, M A M, Delewi, R, van de Hoef, T P, Knaapen, P, Lemkes, J S, Marques, K M, Nap, A, Verouden, N J W, Marije Vis, M, de Winter, R J, Kikkert, W J, Appelman, Y & Henriques, J P S 2023, ' Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients : the OPTICA study ', EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, vol. 19, no. 1, pp. 63-72 . https://doi.org/10.4244/EIJ-D-22-00886

BACKGROUND: Early P2Y12 inhibitor monotherapy has emerged as a promising alternative to 12 months of dual antiplatelet therapy following percutaneous coronary intervention (PCI). AIMS: In this single-arm pilot study, we evaluated the feasibility and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::412535316f031d7962507545f505bbb9
http://www.scopus.com/inward/record.url?scp=85159739007&partnerID=8YFLogxK

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání